Literature DB >> 17428798

Solution structure of human secretory component and implications for biological function.

Alexandra Bonner1, Clémentine Perrier, Blaise Corthésy, Stephen J Perkins.   

Abstract

Secretory component (SC) in association with polymeric IgA (pIgA) forms secretory IgA, the major antibody active at mucosal surfaces. SC also exists in the free form, with innate-like neutralizing properties against pathogens. Free SC consists of five glycosylated variable (V)-type Ig domains (D1-D5), whose structure was determined by x-ray and neutron scattering, ultracentrifugation, and modeling. With a radius of gyration of 3.53-3.63 nm, a length of 12.5 nm, and a sedimentation coefficient of 4.0 S, SC possesses an unexpected compact structure. Constrained scattering modeling based on up to 13,000 trial models shows that SC adopts a J-shaped structure in which D4 and D5 are folded back against D2 and D3. The seven glycosylation sites are located on one side of SC, leaving known IgA-binding motifs free to interact with pIgA. This work represents the first analysis of the three-dimensional structure of full-length free SC and paves the way to a better understanding of the association between SC and its potential ligands, i.e. pIgA and pathogenic-associated motifs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428798     DOI: 10.1074/jbc.M701281200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Small angle neutron and X-ray scattering in structural biology: recent examples from the literature.

Authors:  Cameron Neylon
Journal:  Eur Biophys J       Date:  2008-01-23       Impact factor: 1.733

2.  The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses.

Authors:  Alexandra Bonner; Adel Almogren; Patricia B Furtado; Michael A Kerr; Stephen J Perkins
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

3.  Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights.

Authors:  Stephen J Perkins; Azubuike I Okemefuna; Ruodan Nan; Keying Li; Alexandra Bonner
Journal:  J R Soc Interface       Date:  2009-07-15       Impact factor: 4.118

4.  3D6 and 4B3: Recombinant expression of two anti-gp41 antibodies as dimeric and secretory IgA.

Authors:  David Reinhart; Robert Weik; Renate Kunert
Journal:  BMC Proc       Date:  2011-11-22

5.  C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer.

Authors:  Azubuike I Okemefuna; Lasse Stach; Sudeep Rana; Akim J Ziai Buetas; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Polymeric immunoglobulin receptor traffics through two distinct apically targeted pathways in primary lacrimal gland acinar cells.

Authors:  Shi Xu; Linlin Ma; Eunbyul Evans; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  J Cell Sci       Date:  2013-04-19       Impact factor: 5.285

7.  Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.

Authors:  Azubuike I Okemefuna; Ruodan Nan; Ami Miller; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

8.  SCT: a suite of programs for comparing atomistic models with small-angle scattering data.

Authors:  David W Wright; Stephen J Perkins
Journal:  J Appl Crystallogr       Date:  2015-05-09       Impact factor: 3.304

9.  Multi-faceted functions of secretory IgA at mucosal surfaces.

Authors:  Blaise Corthésy
Journal:  Front Immunol       Date:  2013-07-12       Impact factor: 7.561

10.  The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins.

Authors:  Beth M Stadtmueller; Kathryn E Huey-Tubman; Carlos J López; Zhongyu Yang; Wayne L Hubbell; Pamela J Bjorkman
Journal:  Elife       Date:  2016-03-04       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.